Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse
- PMID: 22962610
- PMCID: PMC3433471
- DOI: 10.1371/journal.pone.0044335
Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse
Abstract
Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated receptors (PPARs) and PPAR γ coactivator-1α (PGC-1α) pathways have been shown to improve mitochondrial function and energy metabolism. The mitochondrial DNA (mtDNA) mutator mouse is a mouse model of aging that harbors a proofreading-deficient mtDNA polymerase γ. These mice develop many features of premature aging including hair loss, anemia, osteoporosis, sarcopenia and decreased lifespan. They also have increased mtDNA mutations and marked mitochondrial dysfunction. We found that mutator mice treated with bezafibrate for 8-months had delayed hair loss and improved skin and spleen aging-like phenotypes. Although we observed an increase in markers of fatty acid oxidation in these tissues, we did not detect a generalized increase in mitochondrial markers. On the other hand, there were no improvements in muscle function or lifespan of the mutator mouse, which we attributed to the rodent-specific hepatomegaly associated with fibrate treatment. These results showed that despite its secondary effects in rodent's liver, bezafibrate was able to improve some of the aging phenotypes in the mutator mouse. Because the associated hepatomegaly is not observed in primates, long-term bezafibrate treatment in humans could have beneficial effects on tissues undergoing chronic bioenergetic-related degeneration.
Conflict of interest statement
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3433471/bin/pone.0044335.g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3433471/bin/pone.0044335.g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3433471/bin/pone.0044335.g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3433471/bin/pone.0044335.g004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3433471/bin/pone.0044335.g005.gif)
Similar articles
-
Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse.Hum Mol Genet. 2012 May 15;21(10):2288-97. doi: 10.1093/hmg/dds049. Epub 2012 Feb 21. Hum Mol Genet. 2012. PMID: 22357654 Free PMC article.
-
Mitochondrial DNA mutations in mutator mice confer respiration defects and B-cell lymphoma development.PLoS One. 2013;8(2):e55789. doi: 10.1371/journal.pone.0055789. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418460 Free PMC article.
-
Dysregulation of mitochondrial quality control processes contribute to sarcopenia in a mouse model of premature aging.PLoS One. 2013 Jul 23;8(7):e69327. doi: 10.1371/journal.pone.0069327. Print 2013. PLoS One. 2013. PMID: 23935986 Free PMC article.
-
Amelioration of premature aging in mtDNA mutator mouse by exercise: the interplay of oxidative stress, PGC-1α, p53, and DNA damage. A hypothesis.Curr Opin Genet Dev. 2016 Jun;38:127-132. doi: 10.1016/j.gde.2016.06.011. Epub 2016 Aug 3. Curr Opin Genet Dev. 2016. PMID: 27497229 Free PMC article. Review.
-
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.Cardiovasc Diabetol. 2005 Sep 16;4:14. doi: 10.1186/1475-2840-4-14. Cardiovasc Diabetol. 2005. PMID: 16168052 Free PMC article. Review.
Cited by
-
Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation.JCI Insight. 2024 Feb 22;9(4):e174097. doi: 10.1172/jci.insight.174097. JCI Insight. 2024. PMID: 38271099 Free PMC article.
-
Recent advances in small molecules for improving mitochondrial disorders.RSC Adv. 2023 Jul 10;13(30):20476-20485. doi: 10.1039/d3ra03313a. eCollection 2023 Jul 7. RSC Adv. 2023. PMID: 37435377 Free PMC article. Review.
-
PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response.Antioxidants (Basel). 2023 May 10;12(5):1075. doi: 10.3390/antiox12051075. Antioxidants (Basel). 2023. PMID: 37237941 Free PMC article. Review.
-
HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models.J Clin Invest. 2022 Apr 15;132(8):e131053. doi: 10.1172/JCI131053. J Clin Invest. 2022. PMID: 35230976 Free PMC article.
-
Tocotrienol Supplementation Led to Higher Serum Levels of Lysophospholipids but Lower Acylcarnitines in Postmenopausal Women: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.Front Nutr. 2021 Dec 24;8:766711. doi: 10.3389/fnut.2021.766711. eCollection 2021. Front Nutr. 2021. PMID: 35004805 Free PMC article.
References
-
- Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, et al. (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417–423. - PubMed
-
- Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481–484. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases